Sildenafil After the Fontan Operation

Summary

Sildenafil After the Fontan Operation is a clinical trial^[1].

Key Facts

• Sildenafil After the Fontan Operation's instance of is recorded as clinical trial^[2].
• Sildenafil After the Fontan Operation's start time is recorded as +2007-12-31T00:00:00Z^[3].
• Sildenafil After the Fontan Operation's end time is recorded as +2009-04-30T00:00:00Z^[4].
• Sildenafil After the Fontan Operation's sponsor is recorded as Children's Hospital of Philadelphia^[5].
• Sildenafil After the Fontan Operation's main subject is recorded as hypoplastic left heart syndrome^[6].
• Sildenafil After the Fontan Operation's main subject is recorded as tricuspid atresia^[7].
• Sildenafil After the Fontan Operation's number of participants is recorded as {'unit': '1', 'amount': '+28'}^[8].
• Sildenafil After the Fontan Operation's title is recorded as The Sildenafil After Fontan Operation Study^[9].
• Sildenafil After the Fontan Operation's short name is recorded as SAFO^[10].
• Sildenafil After the Fontan Operation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+8'}^[11].
• Sildenafil After the Fontan Operation's ClinicalTrials.gov ID is recorded as NCT00507819^[12].
• Sildenafil After the Fontan Operation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}^[13].
• Sildenafil After the Fontan Operation's research intervention is recorded as sildenafil citrate^[14].
• Sildenafil After the Fontan Operation's clinical trial phase is recorded as phase II clinical trial^[15].
• Sildenafil After the Fontan Operation's research subject recruitment status is recorded as completed^[16].
• Sildenafil After the Fontan Operation's study type is recorded as interventional study^[17].